SCHEMBL146839

SCHEMBL146839

c1ccc([Si](N[Si](c2ccccc2)(c2ccccc2)c2ccccc2)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 6/20 0.35
ALDH1A1 P00352 5/20 0.35
HSD17B10 Q99714 2/20 0.35
CTSD P07339 1/20 0.35
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
TSHR P16473 5/20 0.33
RAB9A P51151 3/20 0.33
MAPK1 P28482 2/20 0.33
PTGS2 P35354 2/20 0.33
NPC1 O15118 2/20 0.33
ALOX12 P18054 2/20 0.33
ALOX15 P16050 1/20 0.33
PTGS1 P23219 1/20 0.33
SLC6A2 P23975 1/20 0.33
HTR2B P41595 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
IDO1 P14902 2/20 0.32
LMNA P02545 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7896320 0.83 ESR1 (0.39) ESR1ESR2TSHRRAB9ANPC1
SCHEMBL7685712 0.83 ESR1 (0.39) ESR1ESR2TSHRRAB9ANPC1
SCHEMBL29757964 0.81 ESR1 (0.38) ESR1ESR2TSHRRAB9ANPC1
SCHEMBL49919 0.75 TSHR (0.41) TDP1ALDH1A1HSD17B10CTSDESR1
SCHEMBL2509044 0.75 TSHR (0.35) TDP1ALDH1A1HSD17B10CTSDESR1
SCHEMBL49707 0.73 ALDH1A1 (0.43) TDP1ALDH1A1HSD17B10CTSDTSHR
SCHEMBL30927813 0.73 ESR1 (0.31) TDP1ALDH1A1HSD17B10CTSDESR1
SCHEMBL2268924 0.71 KCNN4 (0.39) ALDH1A1ESR1ESR2TSHRRAB9A
SCHEMBL8763125 0.71 ALDH1A1 (0.44) TDP1ALDH1A1ESR1ESR2TSHR
SCHEMBL11540362 0.69 ATM (0.38) ESR1ESR2TSHRRAB9AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115895546-B Thermosetting resin composition and insulating adhesive film thereof 广东生益科技股份有限公司 2025-01-07 CN claimed
CN-117106483-B Residual oil hydrogenation anti-coking scale inhibitor and preparation method thereof 江苏创新石化有限公司 2024-12-17 CN claimed
CN-117106483-A Residual oil hydrogenation anti-coking scale inhibitor and preparation method thereof 江苏创新石化有限公司 2023-11-24 CN claimed
US-20100004414-A1 POLYMERS FUNCTIONALIZED WITH IMIDE COMPOUNDS CONTAINING A PROTECTED AMINO GROUP BRIDGESTONE CORPORATION (JP) 2010-01-07 US claimed
CN-119894957-A Epoxy resin composition, resin paste, film-type adhesive, printed circuit board, semiconductor chip package, and electronic device 旭化成株式会社 2025-04-25 CN disclosed
CN-119708917-A Inkjet ink, method for forming cured product, and cured product 柯尼卡美能达株式会社 2025-03-28 CN disclosed
CN-112147844-B Photosensitive resin composition 味之素株式会社 2025-01-28 CN disclosed
CN-119365418-A Process for producing spherical silica powder AGC株式会社 2025-01-24 CN disclosed
CN-115895546-B Thermosetting resin composition and insulating adhesive film thereof 广东生益科技股份有限公司 2025-01-07 CN disclosed
CN-119255963-A Silica particle dispersion AGC株式会社 2025-01-03 CN disclosed
CN-112180697-B Toner and method for producing the same 佳能株式会社 2024-12-24 CN disclosed
CN-117106483-B Residual oil hydrogenation anti-coking scale inhibitor and preparation method thereof 江苏创新石化有限公司 2024-12-17 CN disclosed
EP-0900218-A1 HETEROCYCLIC COMPOUNDS ELI LILLY AND COMPANY (US) 1999-03-10 EP disclosed
EP-0900204-A1 HETEROCYCLIC COMPOUNDS ELI LILLY AND COMPANY (US) 1999-03-10 EP disclosed
EP-0874828-A1 COMPOSITION FOR TREATING PAIN ELI LILLY AND COMPANY (US) 1998-11-04 EP disclosed
WO-1997040016-A1 HETEROCYCLIC COMPOUNDS ELI LILLY AND COMPANY (US) 1997-10-30 WO disclosed
WO-1997040044-A1 HETEROCYCLIC COMPOUNDS ELI LILLY AND COMPANY (US) 1997-10-30 WO disclosed
WO-1997040042-A1 HETEROCYCLIC COMPOUNDS ELI LILLY AND COMPANY (US) 1997-10-30 WO disclosed
WO-1997039753-A1 HETEROCYCLIC COMPOUNDS ELI LILLY AND COMPANY (US) 1997-10-30 WO disclosed
WO-1997020819-A1 COMPOSITION FOR TREATING PAIN ELI LILLY AND COMPANY (US) 1997-06-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004414-A1 POLYMERS FUNCTIONALIZED WITH IMIDE COMPOUNDS CONTAINING A PROTECTED AMINO GROUP PARG, PIN1, NPEPPS TDP1 2435/4885ALDH1A1 4339/4885HSD17B10 4844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.